021-51111890
购物车（）
sales@molnova.cn
8-Hydroxy-DPAT hydrobromide
CAS No. 76135-31-4
8-Hydroxy-DPAT hydrobromide ( 8-OH-DPAT hydrobromide )
产品货号. M27597 CAS No. 76135-31-4
8-Hydroxy-DPAT hydrobromide (8-OH-DPAT hydrobromide) is a potent and selective 5-HT1A agonist with a pIC50 of 8.19. 8-Hydroxy-DPAT hydrobromide has a selectivity of almost 1000 fold for a subtype of the 5-HT1 binding site.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥316 | 有现货 |
|
| 10MG | ￥518 | 有现货 |
|
| 25MG | ￥1126 | 有现货 |
|
| 50MG | ￥2066 | 有现货 |
|
| 100MG | ￥3686 | 有现货 |
|
| 500MG | ￥7995 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称8-Hydroxy-DPAT hydrobromide
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述8-Hydroxy-DPAT hydrobromide (8-OH-DPAT hydrobromide) is a potent and selective 5-HT1A agonist with a pIC50 of 8.19. 8-Hydroxy-DPAT hydrobromide has a selectivity of almost 1000 fold for a subtype of the 5-HT1 binding site.
-
产品描述8-Hydroxy-DPAT hydrobromide (8-OH-DPAT hydrobromide) is a potent and selective 5-HT1A agonist with a pIC50 of 8.19. 8-Hydroxy-DPAT hydrobromide has a selectivity of almost 1000 fold for a subtype of the 5-HT1 binding site.
-
同义词8-OH-DPAT hydrobromide
-
通路Endocrinology/Hormones
-
靶点5-HT Receptor
-
受体PARP1
-
研究领域——
-
适应症——
化学信息
-
CAS Number76135-31-4
-
分子量328.3
-
分子式C16H25NO·HBr
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESOC1=C2C[C@H](CCC2=CC=C1)N(CCC)CCC.Br
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Almahli H, Hadchity E, Jaballah MY, Daher R, Ghabbour HA, Kabil MM, Al-Shakliah NS, Eldehna WM. Development of novel synthesized phthalazinone-based PARP-1 inhibitors with apoptosis inducing mechanism in lung cancer. Bioorg Chem. 2018 Apr;77:443-456.
产品手册
关联产品
-
SUVN-502 mesylate hy...
SUVN-502 (SUVN502)is apotent, selective, brain penetrant and orally active 5-HT6 receptor antagonist with Ki of 2.04 nM.
-
Eucalyptol
Eucalyptol inhibits 5-HT-evoked currents in oocytes expressing 5-HT3 receptors with an IC50 of 258 μM.
-
Clomipramine
Clomipramine is a tricyclic antidepressant (TCA). It is used for the treatment of the panic disorder, obsessive-compulsive disorder, major depressive disorder, and chronic pain.
